Concepedia

Fuyong Du

FD

Statistics

Publications

14

Citations

897

H-Index

12

Active since

2006

Affiliations

Janssen (United States)(Current)

Springhouse

Johnson & Johnson (United States)

Temple University

Fuyong Du is an author at Janssen (United States) specializing in pharmacology, molecular pharmacology, and medicinal chemistry.

Publications per year

2006–2022

14

Publications

14

Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models

Yin Liang, Kenji Arakawa, Kiichiro Ueta et al. · PLoS ONE · 2012 · 243 citations · Full text

, , +17

Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation

Xinyuan Li, Pu Fang, Yafeng Li et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 217 citations · Full text

, , +17

Identification and Structure−Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms

Nareshkumar Jain, Jiayi Xu, Ramesh M. Kanojia et al. · Journal of Medicinal Chemistry · 2009 · 99 citations · Full text

, , +13

Metabolomic analyses for atherosclerosis, diabetes, and obesity

Fuyong Du, Anthony Virtue, Hong Wang et al. · Biomarker Research · 2013 · 70 citations · Full text

, , +17

Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile

Graeme Semple, Juerg Lehmann, Amy Wong et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

, , +14

1–5 of 14